US Archives - Page 82 of 185 - European Medical Journal

Optimizing Board Exam Outcomes For Hematology/Oncology Fellows

Certification in Hematology and Oncology requires mastery of increasingly complex clinical knowledge. Despite this, approximately 8% of…

ASCO 2025: Driving Knowledge to Action in Cancer Care

THE 2025 American Society of Clinical Oncology (ASCO) Annual Meeting underscored a key principle: in today’s complex and rapidly…

Current Approaches to Recurrent and Metastatic Cervical Cancer

Despite improved screening and treatment in developing nations, cervical cancer continues to have a global incidence of approximately…

Novel Pharmacology Curriculum in Hematology-Oncology Fellowship Program

Thorough understanding of cancer therapeutics is a critical component of hematology–oncology (HO) training, with pharmacology…

ASCO 2025: Highlights in Breast Cancer Research

THE theme of this year’s American Society of Clinical Oncology (ASCO) Annual Meeting was ‘Driving Knowledge to Action: Building a Better…

High-Grade Gallbladder Neuroendocrine Tumor in a Young Female

Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms that originate from cells of the diffuse neuroendocrine system…

Fertility Outcomes After Immunotherapy in Young Adults

Immune checkpoint inhibitors (ICI) are used to treat multiple types of cancer. However, there are limited studies on the long-term…

Prolonged Survival in Fibrolamellar HCC Treatment

Liver cancer is a leading global health concern, ranking as the sixth most common cancer and the third deadliest in 2022, with over…

ASCO 2025: Evolving Standards in Gastrointestinal Cancers

THIS year’s American Society of Clinical Oncology (ASCO) 2025 gastrointestinal (GI) sessions presented pivotal data across different GI…

Survival Disparities in Epithelial Ovarian Cancer

Ovarian cancer represents a leading cancer-related cause of death among women in the USA, with approximately 20,890 new cases expected to…